1910 Genetics Interview Guide

1910 Genetics is a pioneering Series A stage biotechnology company that is revolutionizing drug discovery through its groundbreaking Input-Transform-Output (ITO™) platform, recognized as the first horizontal AI infrastructure in the industry. The company distinguishes itself within a competitive landscape by providing modality-agnostic drug discovery capabilities, facilitating the design of both small and large molecule therapeutics across a diverse array of disease areas, with a primary focus on neuroscience, oncology, and autoimmune diseases. By harnessing proprietary multimodal data, 1910 Genetics effectively tackles the prevalent issue of data scarcity and employs multi-AI agent systems to overcome complex drug discovery challenges. The company operates a state-of-the-art automated wet laboratory in Boston's Seaport District and has formed a strategic partnership with Microsoft, enabling it to leverage Azure Quantum Elements for enhanced capabilities in advanced AI applications in drug development and discovery.